|
Healthy bodies, healthy lives
News
Welcome to the Dainippon Sumitomo Pharma America, Inc., News Center. This information is intended for U.S. journalists. If you would like information about Dainippon Sumitomo Pharma Company in Japan please visit http://www.ds-pharma.co.jp.
Latest News
March 10, 2010
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
February 19, 2010
Sepracor Announces New Management Changes and Plans For Merger With Dainippon Sumitomo Pharma America
January 04, 2010
Lurasidone NDA Submission PR Jan 2010
August 26, 2009
DSP Lurasidone Demonstrated Efficacy in Treating Patients with Schizophrenia in 2nd Phase 3 Trial
June 3, 2009Lurasidone Study Published in Journal of Clinical Psychiatry
May 20, 2009
DSP Announces Lurasidone Phase III Data In Patients With Schizophrenia
May 11, 2009
Summary of Consolidated Financial Results for the Year Ended March
31, 2009
February 3, 2009
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2009 (PDF 321kb)
Source: Dainippon Sumitomo Pharma Co., Limited
About Us
Leadership
Global Pipeline
For Media Inquires:
Julissa Viana
Director, Communications
Phone: 201-228-8356
Email: media@dsp-a.com
|
|
|
